“borderline significant”

Although RMT also showed a trend toward improved quality of life (SMD 1.00, 95% CI 0.00-1.99; P = .05), this result was borderline significant and derived from only three studies and should therefore be interpreted cautiously.

There was borderline significant directional selection for Pfmdr1 184F in recurrent malaria infections after treatment with AL in Uganda site (p = 0.05).

Results: The obesity-risk-allele score showed borderline significant association with birth weight (0.019 SDS/allele; P = 0.05) and was more clearly associated with higher weight and BMI at all time points between ages 2 and 53 y; the strongest associations with weight occurred at ages 11 and 20 y (both 0.056 SDS/allele).

LTL remained unchanged following the training intervention (pre 0.819 ± 0.121 vs post 0.812 ± 0.114, p = 0.420), despite a borderline significant increase in hTERT expression (p = 0.050).

There remained a borderline significant difference between the two groups following reaming (p = 0.05).

Problem-solving was borderline significant in the univariable analysis (OR = 1.83, p = 0.05) but did not remain significant in the multivariable model (AOR = 1.74, p = 0.20).

Furthermore, metastatic disease was borderline significant as negative predictor for survival (metastatic vs. non-metastatic; 5.3 years vs. not reached; P = 0.05).

A clinical diagnosis of sepsis with unspecified focus of infection was a borderline significant risk factor for enterococcal infection in univariate analysis (OR: 2.0, 95% CI: 1.00-4.00, p = 0.050) and a significant risk factor in multivariate analysis (OR: 2.9, 95% CI: 1.36-6.20, p = 0.006).

However, since most patients who received thoracic RT achieved a complete or partial best response (90.5%), while the subgroup analysis of patients who responded to systemic therapy showed a borderline significant survival benefit ( p = 0.050), the beneficial effect of thoracic RT administered during first‐line treatment can reasonably be regarded as that of consolidative RT in a real‐world clinical setting [ 2 , 19 , 20 ].

There was a significant decrease in the reporting of neonatal sepsis ( p = 0.01) in the bivariate analysis, which remained only borderline significant in the multivariate model ( p = 0.05).

For the older age, anti-HSV antibody was borderline significant (OR: 0.98, 95% CI: 0.97–1.00, P =0.05).

While the use of corticosteroids showed a borderline significant benefit (MD = 1.34, 95% CI: 0.01–2.67, p = 0.05), ALA supplementation did not significantly enhance olfactory recovery (MD = 0.50, 95% CI: −0.07–1.07, p = 0.08).

We observed a borderline significant increased risk for kidney disease (OR: 1.24, 95% CI: 1.00, 1.49, P = 0.05).

administration of RFRP‐3 also tended to increase EGP as indicated by the borderline significant Interaction effect ( P = 0.050) (Figure 7D and Table 4 ). 3.3.

GSR (average) for cases is higher when compared to controls and was borderline significant ( P = 0.05).

Also, a borderline significant change ( p = 0.05) was observed in patients on immunomodulators, as they had a higher incidence of normal (42.2%/30.6%) and non-specific (31.1%/16.7%) and a lower percentage of specific (26.7%/52.8%) findings on upper endoscopy.

Coffee with added sugar showed a significant positive correlation with Bifidobacterium (IVW method: OR = 1.56, 95% CI : 1.05-2.33, P = 0.03) and a borderline significant negative correlation with Veillonella (IVW method: OR = 0.65, 95% CI : 0.423–0.99, P = 0.05).

23); however, we noted a borderline significant increase in stress following the 4-week period after a COVID-19 diagnosis ( P = . 05).

After adjustment, the associations between FTO and baseline BMI remained borderline significant ( p = 0.050).

The difference in proportions in reported findings from the CXRs between the two groups was borderline significant (p=0.05).

There was a significant fibrosis‐adjusted treatment effect for TPIP vs placebo of 3.8% (P = 0.02) onBV5A‐PR and a borderline significant fibrosis‐adjusted treatment effect for TPIP vs placebo of 6.4% (P = 0.05) onBV5A‐PRA.

This non‐physiological correlation was the strongest for sCA estimates in the posterior circulation (VA; r = 0.44; P = 0.03) and borderline significant for the anterior circulation (ICA; r = 0.40; P = 0.05).

Linear Mixed Modelling reported a borderline significant improvement in Processing Speed (t = 1.98, p =.05) for the methylphenidate group.

Among baseline respiratory variables, driving pressure was slightly higher in the supine group (22 ± 5 cmH 2 O) compared to the prone group (18 ± 3 cmH 2 O), showing a borderline significant difference (p = 0.05).

ADHD diagnosis was borderline significant (OR = 1.19, p = 0.050, CI 95% [1.00, 1.42]).